Related Experiment Videos
Identification of an Immunomodulating Agent from Mycobacterium leprae
Yumi Maeda1, Tetsu Mukai, John Spencer
1Department of Microbiology, Leprosy Research Center, National Institute of Infectious Diseases, 4-2-1 Aobacho, Higashimurayama, Tokyo 189-0002, Japan.
Infection and Immunity
|April 23, 2005
Summary
Mycobacterium leprae
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Leprosy is a mycobacterial infection.
- Identifying immunomodulating agents is crucial for treatment.
- Bacterial membranes contain potent antigenic components.
Purpose of the Study:
- To identify immunomodulating proteins from Mycobacterium leprae.
- To investigate the role of these proteins in immune cell activation.
Main Methods:
- Fractionation and antigenicity assessment of Mycobacterium leprae membrane components.
- N-terminal sequencing of serum-reactive proteins.
- Functional assays using monocyte-derived dendritic cells (DCs).
- Analysis of DC surface marker expression and cytokine production.
- Investigation of Toll-like receptor 2 (TLR-2) involvement.
Main Results:
- Major membrane protein II (MMP-II) was identified as a T-cell-activating candidate.
- Purified MMP-II stimulated DCs to produce interleukin-12 p70.
- MMP-II up-regulated MHC class I/II, CD86, and CD83 on DCs.
- TLR-2 signaling mediated MMP-II-induced DC maturation.
Conclusions:
- MMP-II is an immunomodulating protein from Mycobacterium leprae.
- MMP-II activates antigen-presenting cells and innate immunity via TLR-2.
- MMP-II shows potential for therapeutic applications in immune modulation.